Why shareholders are suing Novo Nordisk over next-generation weight-loss drug
--------------------------------------------------------------------
Source: CNBC
Published: 2026-07-29 23:11 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Politics, Health, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
A federal judge on Tuesday allowed parts of that lawsuit to move forward, finding that investors had plausibly alleged that some statements about CagriSema's tolerability and the design of the late-stage trial may have been misleading.
--------------------------------------------------------------------